Director Stock Transaction Filing

Temeng Kwaku, a director at Core Laboratories Inc. /DE/, acquired 7,895 restricted shares of Common Stock on April 1, 2026. These shares vested at the end of a one-year period ending April 1, 2026, and will be distributed following separation from service. The filing also notes the acquisition of 8,069 shares of Common Stock, bringing the total post-transaction shares to 33,597. The shares were acquired at no cost, with a post-transaction value of 0.